Amanda Langston

WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Artificial intelligence is increasingly used across the medicines lifecycle, and regulators have articulated high-level principles for its trustworthy use, including requirements related to transparency, data governance, and ethics. The EU Artificial Intelligence Act establishes a horizontal legal framework for AI systems but does not define how AI-generated evidence should be evaluated in the context of medicines regulation.